SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 18, 2016 PRIMARY DOCUMENT
4 Jul 18, 2016 PRIMARY DOCUMENT
4 Jul 18, 2016 PRIMARY DOCUMENT
4 Jul 18, 2016 PRIMARY DOCUMENT
8-K Jul 18, 2016 8-K
8-K Jul 18, 2016 FORM 8-K
SC 13G Jul 15, 2016 SC 13G
SC 13G Jul 12, 2016 SABBY 13G GALE 6.12.16
8-K Jul 12, 2016 8-K
DEFA14A Jul 8, 2016 DEFA14A
4 Jul 8, 2016 PRIMARY DOCUMENT
424B5 Jul 8, 2016 424B5
8-K Jul 8, 2016 FORM 8-K
4 Jul 6, 2016 PRIMARY DOCUMENT
4 Jul 6, 2016 PRIMARY DOCUMENT
8-K Jun 29, 2016 8-K
8-K Jun 28, 2016 8-K
DEFA14A Jun 9, 2016 DEFA14A
4 Jun 7, 2016 PRIMARY DOCUMENT
NO ACT Jun 6, 2016 AUTO-GENERATED PAPER DOCUMENT
DEFA14A Jun 3, 2016 DEFA14A
DEF 14A Jun 3, 2016 DEF 14A
PRE 14A May 24, 2016 PRELIMINARY PROXY STATEMENT
D May 24, 2016
10-Q May 10, 2016 10-Q
← Newer Page 26 of 51 · 1272 filings Older →